Jefferies Group’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
ACM
WHG
Jefferies Group's BSX.PRA Position: Q1 2022 in Review
Jefferies Group sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q1 2022, closing a stake of 19,812 shares — an estimated $2.27M sold.
Jefferies Group first reported a position in BSX.PRA in Q4 2021 and held it in 1 quarter. The position peaked at $2.27M in Q4 2021. 44 funds tracked by Wall St. Rank hold BSX.PRA as of Q1 2022.
- Jefferies Group reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q1 2022 after selling out during the quarter.
- Jefferies Group sold 19,812 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q1 2022, an estimated $2.27M.
- Jefferies Group first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q4 2021 and held it in 1 quarter.
- Jefferies Group's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $2.27M in Q4 2021.
- 44 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q1 2022.
Based on Jefferies Group's 13F filing for Q1 2022, filed 16 May 2022.